Candel Therapeutics (CADL) Stock Price, Quote, News & History

Q: What sector and industry does Candel Therapeutics (CADL) operate in?

Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Candel Therapeutics (CADL) Stock Price, Quote, News & History

CADLNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$5.84

-0.09-1.52%

At close: Jan 30, 4:00 PM EST

$5.79

-0.05-0.86%

After Hours: 6:49 PM EST

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$5.87

Close

$5.84

Volume / Avg.

559.93K / 793.83K

Day Range

$5.80 - $6.11

52 Wk Range

4.25 - 13.68

Market Cap

$317.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

21.14%

Days to Cover

14.58

Recent Candel Therapeutics Inc News

Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

EXCLUSIVE: Trinity Capital's New Loan Fuels Bobbie's Mission To Set New US Infant Nutrition Standards

Trinity Capital Inc. announced a financing agreement with Bobbie, an organic infant nutrition company, to boost production capacity and ensure wider distribution of its products.

Akanksha Bakshi

ASML, J B Hunt Transport And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-33.56M

Investing Cash Flow (TTM)

-154.00K

Financing Cash Flow (TTM)

104.12M

Free Cash Flow (TTM)

-33.74M

Capital Expenditure (TTM)

-181.00K

Net Change in Cash (TTM)

70.41M

Analyst Trends and Forecast

1

Sep 25

2

Oct 25

1

Nov 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$246.61M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

4.07

Earnings Yield % (TTM)

-9.42%

Earnings Yield % (FWD)

-16.99%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.46

Company Debt

Total Debt

$5.20M

LT Debt

$973.00K

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$10.00M

Total Cash

$86.96M

Debt to Equity

0.09

Issuance of Debt (TTM)

-$10.00M

Repayment of Debt (TTM)

-$10.00M

Key Statistics

Open

$5.87

Close

$5.84

Volume / Avg.

559.93K / 793.83K

Day Range

$5.80 - $6.11

52 Wk Range

4.25 - 13.68

Market Cap

$317.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

21.14%

Days to Cover

14.58

About

Sector

Health Care

Industry

Biotechnology

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Candel Therapeutics (CADL) stock?

A

You can purchase shares of Candel Therapeutics (NASDAQ:CADL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Candel Therapeutics (CADL) competitors?

A

Other companies in Candel Therapeutics’s space includes: Burning Rock Biotech Ltd (NASDAQ:BNR), Larimar Therapeutics Inc (NASDAQ:LRMR), Immuneering Corp (NASDAQ:IMRX), PepGen Inc (NASDAQ:PEPG) and AC Immune SA (NASDAQ:ACIU).

Q

What is the forecast, or price target, for Candel Therapeutics (CADL) stock?

A

Candel Therapeutics has a consensus price target of $16.20.

Q

What is the current price for Candel Therapeutics (CADL)?

A

The stock price for Candel Therapeutics (NASDAQ: CADL) is $5.79 last updated January 30, 2026 at 6:49 PM EST.

Q

Does Candel Therapeutics (CADL) pay a dividend?

A

There are no upcoming dividends for Candel Therapeutics.

Q

When is Candel Therapeutics (NASDAQ:CADL) reporting earnings?

A

Candel Therapeutics does not have any upcoming earnings scheduled.

Q

Is Candel Therapeutics (CADL) going to split?

A

There is no upcoming split for Candel Therapeutics.

Q

What sector and industry does Candel Therapeutics (CADL) operate in?

A

Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Burning Rock Biotech Ltd

NASDAQ:BNR

$33.55

-1.52%

Larimar Therapeutics Inc

LCTX

Crescent Biopharma Inc

NASDAQ:CBIO

$9.54

-0.52%

Aldeyra Therapeutics Inc

NASDAQ:ALDX

$5.36

%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$5.87

Close

$5.84

Volume / Avg.

559.93K / 793.83K

Day Range

$5.80 - $6.11

52 Wk Range

4.25 - 13.68

Market Cap

$317.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

21.14%

Days to Cover

14.58

Recent Candel Therapeutics Inc News

Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

EXCLUSIVE: Trinity Capital's New Loan Fuels Bobbie's Mission To Set New US Infant Nutrition Standards

Trinity Capital Inc. announced a financing agreement with Bobbie, an organic infant nutrition company, to boost production capacity and ensure wider distribution of its products.

Akanksha Bakshi

ASML, J B Hunt Transport And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-33.56M

Investing Cash Flow (TTM)

-154.00K

Financing Cash Flow (TTM)

104.12M

Free Cash Flow (TTM)

-33.74M

Capital Expenditure (TTM)

-181.00K

Net Change in Cash (TTM)

70.41M

Analyst Trends and Forecast

1

Sep 25

2

Oct 25

1

Nov 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$246.61M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

4.07

Earnings Yield % (TTM)

-9.42%

Earnings Yield % (FWD)

-16.99%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.46

Company Debt

Total Debt

$5.20M

LT Debt

$973.00K

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$10.00M

Total Cash

$86.96M

Debt to Equity

0.09

Issuance of Debt (TTM)

-$10.00M

Repayment of Debt (TTM)

-$10.00M

Key Statistics

Open

$5.87

Close

$5.84

Volume / Avg.

559.93K / 793.83K

Day Range

$5.80 - $6.11

52 Wk Range

4.25 - 13.68

Market Cap

$317.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

21.14%

Days to Cover

14.58

About

Sector

Health Care

Industry

Biotechnology

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry